No connection

Search Results

LNSR vs SRTS

LNSR
LENSAR, Inc.
BEARISH
Price
$5.70
Market Cap
$68.9M
Sector
Healthcare
AI Confidence
95%
SRTS
Sensus Healthcare, Inc.
BEARISH
Price
$4.49
Market Cap
$73.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
LNSR
--
SRTS
--
Forward P/E
LNSR
-8.03
SRTS
70.9
P/B Ratio
LNSR
-2.63
SRTS
1.54
P/S Ratio
LNSR
1.18
SRTS
2.69
EV/EBITDA
LNSR
-3.36
SRTS
-5.27

Profitability

Gross Margin
LNSR
46.41%
SRTS
43.18%
Operating Margin
LNSR
-116.03%
SRTS
-63.74%
Profit Margin
LNSR
-58.66%
SRTS
-28.09%
ROE
LNSR
-1069.41%
SRTS
-14.85%
ROA
LNSR
-22.31%
SRTS
-11.18%

Growth

Revenue Growth
LNSR
-4.2%
SRTS
-62.2%
Earnings Growth
LNSR
--
SRTS
--

Financial Health

Debt/Equity
LNSR
--
SRTS
0.01
Current Ratio
LNSR
1.15
SRTS
9.72
Quick Ratio
LNSR
0.6
SRTS
5.96

Dividends

Dividend Yield
LNSR
--
SRTS
--
Payout Ratio
LNSR
0.0%
SRTS
0.0%

AI Verdict

LNSR BEARISH

LNSR exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.63, indicating negative shareholder equity. The company is suffering from catastrophic profitability metrics, including an ROE of -1069.41% and an operating margin of -116.03%. Despite a 'strong_buy' analyst consensus from a very small sample (2 analysts), the fundamental data shows declining revenue (-4.20% YoY) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The technical trend is aggressively bearish, with a 51.6% price collapse in the last month alone.

Strengths
Positive gross margin of 46.41%
Relatively low Price-to-Sales ratio of 1.18
Current ratio of 1.15 provides a marginal liquidity cushion
Risks
Negative equity (P/B -2.63) indicating insolvency risk
Severe operational inefficiency with -116.03% operating margin
Negative revenue growth (-4.20% YoY) suggesting loss of market share
SRTS BEARISH

SRTS exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY revenue decline of 62.20%. While the company maintains a strong liquidity position with a Current Ratio of 9.72 and negligible debt, these are offset by negative operating margins (-63.74%) and a consistent failure to meet earnings estimates. The recent short-term price appreciation contradicts the underlying financial decay and the bearish technical trend score of 0/100. Overall, the company is in a state of operational distress despite its clean balance sheet.

Strengths
Extremely low leverage (Debt/Equity: 0.01)
High short-term liquidity (Current Ratio: 9.72)
Positive Gross Margin (43.18%)
Risks
Severe revenue collapse (-62.20% YoY)
Deeply negative operating margins (-63.74%)
Poor earnings quality (Piotroski F-Score: 2/9)

Compare Another Pair

LNSR vs SRTS: Head-to-Head Comparison

This page compares LENSAR, Inc. (LNSR) and Sensus Healthcare, Inc. (SRTS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile